Literature DB >> 12860410

Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells.

A Fanzani1, R Giuliani, F Colombo, D Zizioli, M Presta, A Preti, S Marchesini.   

Abstract

Cytosolic sialidase Neu2 has been implicated in myoblast differentiation. Here we observed a significant upregulation of Neu2 expression during differentiation of murine C2C12 myoblasts. This was evidenced both as an increase in Neu2 mRNA steady-state levels and in the cytosolic sialidase enzymatic activity. To understand the biological significance of Neu2 upregulation in myoblast differentiation, C2C12 cells were stably transfected with the rat cytosolic sialidase Neu2 cDNA. Neu2 overexpressing clones were characterized by a marked decrement of cell proliferation and by the capacity to undergo spontaneous myoblast differentiation also when maintained under standard growth conditions. This was evidenced by the formation of myogenin-positive myotubes and by a significant decrease in the nuclear levels of cyclin D1 protein. No differentiation was on the contrary observed in parental and mock-transfected cells under the same experimental conditions. The results indicate that Neu2 upregulation per se is sufficient to trigger myoblast differentiation in C2C12 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860410     DOI: 10.1016/s0014-5793(03)00709-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Sialidase significance for cancer progression.

Authors:  Taeko Miyagi; Kohta Takahashi; Keiko Hata; Kazuhiro Shiozaki; Kazunori Yamaguchi
Journal:  Glycoconj J       Date:  2012-05-29       Impact factor: 2.916

2.  NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis.

Authors:  Luigi Anastasia; Nadia Papini; Francesca Colazzo; Giacomo Palazzolo; Cristina Tringali; Loredana Dileo; Marco Piccoli; Erika Conforti; Clementina Sitzia; Eugenio Monti; Maurilio Sampaolesi; Guido Tettamanti; Bruno Venerando
Journal:  J Biol Chem       Date:  2008-10-22       Impact factor: 5.157

3.  A change in nuclear pore complex composition regulates cell differentiation.

Authors:  Maximiliano A D'Angelo; J Sebastian Gomez-Cavazos; Arianna Mei; Daniel H Lackner; Martin W Hetzer
Journal:  Dev Cell       Date:  2012-01-19       Impact factor: 12.270

4.  Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.

Authors:  Yanhong Li; Hongzhi Cao; Hai Yu; Yi Chen; Kam Lau; Jingyao Qu; Vireak Thon; Go Sugiarto; Xi Chen
Journal:  Mol Biosyst       Date:  2011-01-04

5.  Sialidase specificity determined by chemoselective modification of complex sialylated glycans.

Authors:  Randy B Parker; Janet E McCombs; Jennifer J Kohler
Journal:  ACS Chem Biol       Date:  2012-06-26       Impact factor: 5.100

6.  Modification of sialidase levels and sialoglycoconjugate pattern during erythroid and erytroleukemic cell differentiation.

Authors:  Cristina Tringali; Luigi Anastasia; Nadia Papini; Anna Bianchi; Luisa Ronzoni; Maria Domenica Cappellini; Eugenio Monti; Guido Tettamanti; Bruno Venerando
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

7.  The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.

Authors:  Sang W Hyun; Anguo Liu; Zhenguo Liu; Alan S Cross; Avelino C Verceles; Sadagopan Magesh; Yadagiri Kommagalla; Chandrababunaidu Kona; Hiromune Ando; Irina G Luzina; Sergei P Atamas; Kurt H Piepenbrink; Eric J Sundberg; Wei Guang; Hideharu Ishida; Erik P Lillehoj; Simeon E Goldblum
Journal:  Glycobiology       Date:  2016-05-25       Impact factor: 4.313

8.  Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt/mTOR-mediated pathway in pancreatic cancer cells.

Authors:  Shalini Nath; Chhabinath Mandal; Uttara Chatterjee; Chitra Mandal
Journal:  Cell Death Dis       Date:  2018-02-12       Impact factor: 8.469

9.  Implications for the mammalian sialidases in the physiopathology of skeletal muscle.

Authors:  Alessandro Fanzani; Alessandra Zanola; Fiorella Faggi; Nadia Papini; Bruno Venerando; Guido Tettamanti; Maurilio Sampaolesi; Eugenio Monti
Journal:  Skelet Muscle       Date:  2012-11-01       Impact factor: 4.912

10.  Structural basis for substrate specificity of mammalian neuraminidases.

Authors:  Victoria Smutova; Amgad Albohy; Xuefang Pan; Elena Korchagina; Taeko Miyagi; Nicolai Bovin; Christopher W Cairo; Alexey V Pshezhetsky
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.